Category: Approval/Launch Region: North America · United States Company: Dr Reddys Laboratories Inc

Dr Reddys Launches Generic Oral Anti-Epileptic Drug In Us

Dr Reddys Launches Generic Oral Anti-Epileptic Drug In Us
Drug Firm Dr Reddys Laboratories On Tuesday Said It Has Launched Generic Anti-Epileptic Vigabatrin Powder For Oral Solution In The Us Market. The Product Is A Generic Version Of Lundbecks Sabril Powder For Oral Solution, Dr Reddys Said In A Filing To The Bse. The Company Has Launched Vigabatrin Powder For Oral Solution, Usp In 500 Mg Per Packet After Getting Approval By The United States Food And Drug Administration (Usfda), It Said.

Found this useful? Share it with your team.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!